AAAAAA
Results: 1-25/71
Authors:
HOSOJIMA H
UCHIDA K
Citation: H. Hosojima et K. Uchida, AVAILABILITY OF AN ANTIPLATETLET AGGREGATION INHIBITOR, TICLOPIDINE, IN THE TREATMENT OF GRAVES OPHTHALMOPATHY, Journal of drug development and clinical practice, 8(3), 1996, pp. 129-133
Authors:
JEREMY JY
MEHTA D
ANGELINI GD
Citation: Jy. Jeremy et al., PATHOPHYSIOLOGY AND TREATMENT OF VEIN GRAFT DISEASE FOLLOWING CORONARY-ARTERY BYPASS GRAFT-SURGERY, Journal of drug development and clinical practice, 8(3), 1996, pp. 135-150
Authors:
BERGFELD WF
Citation: Wf. Bergfeld, TOPICAL RETINOIDS IN THE MANAGEMENT OF ACNE-VULGARIS, Journal of drug development and clinical practice, 8(3), 1996, pp. 151-160
Authors:
LIP GYH
BEEVERS DG
Citation: Gyh. Lip et Dg. Beevers, A SURVEY OF THE CURRENT PRACTICE OF TREATING HYPERTENSION IN PRIMARY-CARE - THE RATIONAL EVALUATION AND CHOICE IN HYPERTENSION (REACH) STUDY, Journal of drug development and clinical practice, 8(3), 1996, pp. 161-169
Authors:
GANOTAKIS ES
JAGROOP IA
HAMILTON G
WINDER AF
MIKHAILIDIS DP
Citation: Es. Ganotakis et al., PRELIMINARY-REPORT - CIPROFIBRATE-FLUVASTATIN COMBINATION THERAPY FORDYSLIPIDEMIA, Journal of drug development and clinical practice, 8(3), 1996, pp. 171-175
Authors:
UKERUN SO
Citation: So. Ukerun, CHEMICAL MOSAICS - PERHYDRO-1,2-CYCLOPENTENOPHENANTHRENE STEROIDS, Journal of drug development and clinical practice, 8(3), 1996, pp. 177-178
Authors:
DUNCAN NE
SUMMERS RL
DICKEY S
ARMSTRONG BA
Citation: Ne. Duncan et al., PRIAPISM INDUCED AFTER A SINGLE-DOSE OF TRAZODONE, Journal of drug development and clinical practice, 8(3), 1996, pp. 179-181
Authors:
MAHENDRAN R
Citation: R. Mahendran, BRIEF PSYCHOTIC EPISODE ASSOCIATED WITH PHENYTOIN TOXICITY, Journal of drug development and clinical practice, 8(3), 1996, pp. 183-185
Authors:
KAMLANA SH
Citation: Sh. Kamlana, A CASE OF FEAR OF EMITTING BODY ODOR - A REMARKABLE RESPONSE TO PIMOZIDE, Journal of drug development and clinical practice, 8(3), 1996, pp. 187-189
Authors:
GANOTAKIS ES
MIKHAILIDIS DP
Citation: Es. Ganotakis et Dp. Mikhailidis, CARDIOVASCULAR RISK FACTOR MANAGEMENT - NEW DRUGS WILL PROVIDE A BRIGHT FUTURE, Journal of drug development and clinical practice, 8(2), 1996, pp. 57-60
Authors:
METELITSA VI
DOUDA SG
OSTROVSKAYA TP
FILATOVA NP
MUHAMEDGANOVA GF
VYGODIN VA
BROER M
SIEGRIST J
Citation: Vi. Metelitsa et al., LONG-TERM MONOTHERAPY WITH ANTIHYPERTENSIVES AND QUALITY-OF-LIFE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL-HYPERTENSION - A MULTICENTER STUDY, Journal of drug development and clinical practice, 8(2), 1996, pp. 61-76
Authors:
LETZEL H
HAAN J
FEIL WB
Citation: H. Letzel et al., NOOTROPICS - EFFICACY AND TOLERABILITY OF PRODUCTS FROM 3 ACTIVE-SUBSTANCE CLASSES, Journal of drug development and clinical practice, 8(2), 1996, pp. 77-94
Authors:
VANAELST FJ
BEIJNEN JH
VANTELLINGEN O
VLASVELD LT
HUININK WWT
DUBBELMAN AC
AARTSEN EJ
RODENHUIS S
Citation: Fj. Vanaelst et al., DEVELOPMENT OF A COMBINED INTRAVENOUS AND INTRAPERITONEAL REGIMEN OF FLUOROURACIL AND LEUCOVORIN, Journal of drug development and clinical practice, 8(2), 1996, pp. 95-100
Authors:
ELISAF MS
BAIRAKTARI ET
TZALLAS CS
SIAMOPOULOS KC
Citation: Ms. Elisaf et al., THE HYPOLIPEMIC EFFECTIVENESS OF ANTACIDS CONTAINING ALUMINUM ALONE AND IN COMBINATION WITH SMALL DOSES OF PRAVASTATIN, Journal of drug development and clinical practice, 8(2), 1996, pp. 101-107
Authors:
ANAND R
GHARABAWI G
ENZ A
Citation: R. Anand et al., EFFICACY AND SAFETY RESULTS OF THE EARLY PHASE STUDIES WITH EXELON(TM) (ENA-713) IN ALZHEIMERS-DISEASE - AN OVERVIEW, Journal of drug development and clinical practice, 8(2), 1996, pp. 109-116
Authors:
ANAND R
GHARABAWI G
Citation: R. Anand et G. Gharabawi, CLINICAL DEVELOPMENT OF EXELON(TM) (ENA-713) - THE ADENA(R) PROGRAM, Journal of drug development and clinical practice, 8(2), 1996, pp. 117-122
Authors:
FOTHERBY K
Citation: K. Fotherby, THROMBOSIS AND THE PILL, Journal of drug development and clinical practice, 8(1), 1996, pp. 1-5
Authors:
SHERIDAN WP
TO LB
BROWN SL
GRIGG A
FOOTE MA
JUTTNER CA
Citation: Wp. Sheridan et al., THE CLINICAL USE OF RHUG-CSF (FILGRASTIM)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR THE TRANSPLANTATION, Journal of drug development and clinical practice, 8(1), 1996, pp. 7-17
Authors:
MIKHAILIDIS DP
SPYROPOULOS KA
Citation: Dp. Mikhailidis et Ka. Spyropoulos, THE EFFECT OF TAMOXIFEN ON LIPID AND HEMOSTATIC PREDICTORS OF ISCHEMIC-HEART-DISEASE, Journal of drug development and clinical practice, 8(1), 1996, pp. 19-24
Authors:
MOSIEWICZ J
JASZYNA M
HANZLIK J
RYCZAK E
MAKARUK B
MYSLINSKI W
Citation: J. Mosiewicz et al., SMOKING AND BRONCHIAL REACTIVITY IN SMALL AIRWAYS DISEASE IN A POPULATION OF BOGDANKA (POLAND) COAL-MINERS, Journal of drug development and clinical practice, 8(1), 1996, pp. 25-30
Authors:
SUMMERS RL
DANIELSON DH
SMITH MJ
ADAIR TH
GALLI RL
Citation: Rl. Summers et al., THE EFFECTS OF SALMETEROL ON THEOPHYLLINE PROTEIN-BINDING IN-VITRO, Journal of drug development and clinical practice, 8(1), 1996, pp. 31-33
Authors:
CLARK JE
PARILLON AG
Citation: Je. Clark et Ag. Parillon, EDEMA AND SIGNS OF STROKE IN A PATIENT RECEIVING CARBAMAZEPINE AND FLUVOXAMINE, Journal of drug development and clinical practice, 8(1), 1996, pp. 35-38
Authors:
HUCKLE PL
DAVIES M
Citation: Pl. Huckle et M. Davies, THE USE OF RISPERIDONE IN NEUROLEPTIC-REFRACTORY SCHIZOPHRENIA, Journal of drug development and clinical practice, 8(1), 1996, pp. 39-41
Authors:
KAMLANA SH
Citation: Sh. Kamlana, USE OF RISPERIDONE IN KORSAKOFF PSYCHOSIS PATIENTS, Journal of drug development and clinical practice, 8(1), 1996, pp. 43-44
Authors:
ORTEGA L
IRUELA LM
IBANEZROJO V
BACA E
Citation: L. Ortega et al., ZOLPIDEM AFTER LONG-ACTING BENZODIAZEPINES - POSSIBLE INTERACTION, Journal of drug development and clinical practice, 8(1), 1996, pp. 45-46